Efficacy and safety of insulin pump treatment in adult T1DM patients - influence of age and social environment

Annals of Agricultural and Environmental Medicine

Volumn 19, Issue 3, 2012, Pages 573-575

  Grzanka, Małgorzata ^a   Matejko, Bartłomiej ^a   Cyganek, Katarzyna ^a,b   Kozek, Elzbieta ^a,b   Malecki, Maciej T ^a,b   Klupa, Tomasz ^a,b  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b UNIVERSITY HOSPITAL IN KRAKOW   (Poland)

Author keywords

Continuous subcutaneous insulin infusion; Diabetes; Insulin pump

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADULT; AGE; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PATIENT ATTITUDE; PROGNOSIS; SELF MONITORING; SOCIAL ENVIRONMENT;

ADULT; AGE FACTORS; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INFUSION PUMPS, IMPLANTABLE; INSULIN; INSULIN INFUSION SYSTEMS; POLAND; RETROSPECTIVE STUDIES; SOCIAL ENVIRONMENT; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 84866668611     PISSN: 12321966     EISSN: 18982263     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329(14): 977-986.
2. Pickup J, Keen H. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care. 2002; 25(3): 593-8.
3. Hoogma RP, Hammond PJ, Gomis R, Kerr D, Bruttomesso D, Bouter KP, et al. 5-Nations Study Group. Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial. Diabet Med. 2006; 23(2): 141-7.
4. Bruttomesso D, Costa S, Baritussio A. Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy. Diabetes Metab Res Rev. 2009; 25(2): 99-111.
5. Pickup JC, Keen H, Parsons JA, Alberti KGMM. Continuous subcutaneous insulin infusion: an approach to achieving normoglycemia. Br Med J. 1978; 1(6107): 204-207.
6. Pickup J, Keen H. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care. 2002; 25(3): 593-8.
7. Bode BW, Tamborlane WV, Davidson PC. Insulin pump therapy in the 21st century. Strategies for successful use in adults, adolescents, and children with diabetes. Postgrad Med. 2002; 111(5): 69-77.
8. Nicolucci A, Maione A, Franciosi M, Amoretti R, Busetto E, Capani F, et al. Quality of life and treatment satisfaction in adults with Type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injections. http://www.ncbi.nlm.nih.gov/pubmed/18201210 (access: 2012. 05. 08).
9. Barnard KD, Lloyd CE, Skinner TC. Systematic literature review: quality of life associated with insulin pump use in Type 1 diabetes. Diabet Med. 2007; 24: 607-617.
10. Matejko B, Cyganek K, Katra B, Galicka-Latala D, Grzanka M, Malecki MT, Klupa T. Insulin pump therapy is equally effective and safe in elderly and young type 1 diabetes patients. Rev Diabet Stud. 2011; 8(2): 254-8.
11. Cukierman-Yaffe T, Konvalina N, Cohen O. Key elements for successful intensive insulin pump therapy in individuals with type 1 diabetes. Diabetes Res Clin Pract. 2011;92(1): 69-73.
12. Bode BW, Tamborlane WV, Davidson PC. Insulin pump therapy in the 21st century. Strategies for successful use in adults, adolescents, and children with diabetes. Postgrad Med. 2002; 111(5): 69-77.
13. Hamburg BA. Psychosocial development. In: Friedman SB, et al., editors. Comprehensive Adolescent Health Care. 2. St. Louis; Mosby: 1998. pp. 38-49.
14. Davidson M, Penney ED, Muller B, Grey M. Stressors and self-care challenges faced by adolescents living with type 1 diabetes. Appl Nurs Res. 2004; 17:72-80.
15. Schilling LS, Knafl KA, Grey M. Changing patterns of self-management in youth with type I diabetes. J Pediatr Nurs. 2006; 21: 412-424.
16. Comeaux SJ, Jaser SS. Autonomy and insulin in adolescents with type 1 diabetes. Pediatr Diabetes. 2010; 11(7): 498-504.
17. Pańkowska E, Szypowska A, Lipka M, Szpotańska M, Błazik M, Groble L. Application of novel dual wale meal bolus and its impact on glycated hemoglobin A1c level In children with type 1 diabetes. Pediatr Diabetes. 2009; 10(5): 298-303.
18. Klupa T, Skupien J, Cyganek K, Katra B, Sieradzki J, Malecki MT. The dual-wave bolus feature in type 1 diabetes adult users of insulin pumps. Acta Diabetol. 2011; 48(1): 11-4.
19. Ziegler R, Heidtmann B, Hilgard D, Hofer S, Rosenbauer J, Holl R. Frequency of SMBGcorrelates with HbA1c and acute complications in children and adolescents with type 1 diabetes. http://www.ncbi.nlm. nih.gov/pubmed/20337978 (access: 2012. 05. 08).
20. Garg SK. Glucose Monitoring: An Important Tool for Improving Glucose Control and Reducing Hypoglycemia. http://www.liebertonline.com/doi/abs/10.1089/dia.2008.0008 (access: 2012. 05. 08).